[The efficacy of using Zanocin in infectious diseases].
作者信息
Rudenko A A, Shapiro A V, Kononenko V V, Muravskaia L V, Diadiun S T, Okruzhnov N V, Sidorova Zh P
出版信息
Lik Sprava. 1996 Mar-Apr(3-4):140-3.
PMID:9035852
Abstract
摘要
相似文献
1
[The efficacy of using Zanocin in infectious diseases].[使用 Zanocin 治疗传染病的疗效]
Lik Sprava. 1996 Mar-Apr(3-4):140-3.
2
[Combination chemotherapy of drug-resistant tuberculosis with inclusion of ofloxacin (zanocin)].
Antibiot Khimioter. 2001;46(8):9-18.
3
Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.对左氧氟沙星的耐药性与肺炎球菌肺炎治疗失败
N Engl J Med. 2002 Mar 7;346(10):747-50. doi: 10.1056/NEJMoa012122.
4
5
Clinical efficacy of the new quinolones in lower respiratory infections.
Chemioterapia. 1987 Jun;6(2 Suppl):447-8.
6
[A clinical evaluation of the efficacy of using Zanocin (ofloxacin) in surgery].[使用赞诺欣（氧氟沙星）进行手术的疗效临床评估]
Klin Khir. 1995(9-10):18-9.
7
Levofloxacin-resistant pneumococcus.左氧氟沙星耐药肺炎球菌
Clin Infect Dis. 2000 Aug;31(2):626-7. doi: 10.1086/313958.
8
[Use of ofloxacin in the treatment of suppurative-inflammatory complications in surgery].[氧氟沙星在外科化脓性炎症并发症治疗中的应用]
Anesteziol Reanimatol. 1997 May-Jun(3):18-20.
9
The 2016 JAID/JSC guidelines for clinical management of infectious disease-Odontogenic infections.2016年牙源性感染的《牙科学与口腔颌面外科学杂志》传染病临床管理指南。
J Infect Chemother. 2018 May;24(5):320-324. doi: 10.1016/j.jiac.2017.09.014. Epub 2018 Mar 1.
10
Levofloxacin, a new quinolone antibacterial agent. An introductory overview.左氧氟沙星，一种新型喹诺酮类抗菌剂。简介概述。
Arzneimittelforschung. 1992 Mar;43(3A):363-4.
Zotero 插件